Histotype
Leukemia [AML]
| Parameter | Information |
|---|---|
| Strain | NSG |
| Implant Type | Cells |
| Implant Location | IV |
| Time to Staging | 7 days |
| Time to Evaluation Size (days) | 35.9 days |
| Td | 3.0 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Human
2878